Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia

David J. Kuter*, Merlin Efraim, Jiri Mayer, Marek Trněný, Vickie McDonald, Robert Bird, Thomas Regenbogen, Mamta Garg, Zane Kaplan, Nikolay Tzvetkov, Philip Y. Choi, A. J.Gerard Jansen, Milan Kostal, Ross Baker, Jaromir Gumulec, Eun Ju Lee, Ilona Cunningham, Isaac Goncalves, Margaret Warner, Ralph BocciaTerry Gernsheimer, Waleed Ghanima, Olga Bandman, Regan Burns, Ann Neale, Dolca Thomas, Puneet Arora, Beiyao Zheng, Nichola Cooper

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia'. Together they form a unique fingerprint.

Medicine and Dentistry